Vanderbilt University Medical Center has received a six-year, $31.6 million federal grant to lead a national effort to better understand acute respiratory distress syndrome (ARDS), pneumonia and sepsis, which together kill hundreds of thousands of people in the United States each year.
Pulmonary macrophages are a heterogeneous population of immune cells that patrol the lungs, ingesting particulates and microbes, and activating inflammation when necessary.
The 2022 Vanderbilt Translational Research Forum exemplified the range of studies conducted at Vanderbilt University Medical Center that
BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biologica
Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical
New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 31 for research excellence during t
Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops.
One consequence of the COVID-19 pandemic is the continued erosion of trust in health care, a growing rift between doctor and patient epitomized by large numbers of people who hesitate or refuse to be vaccinated against the virus.
Tacrolimus — a commonly used immunosuppressive drug for lung transplant recipients — requires strict monitoring of concentrations because of variability in metabolism and adverse effects at high levels.
